An open label pilot trial of low-dose lithium for young people at ultra-high risk for psychosis.

Autor: Rice SM; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia., Nelson B; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia., Amminger GP; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia., Francey SM; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia., Phillips LJ; Melbourne School of Psychological Sciences, The University of Melbourne, Melbourne, Victoria, Australia., Simmons MB; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia., Ross M; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia., Yuen HP; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia., Yung AR; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.; Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Victoria, Australia.; Division of Psychology and Mental Health, School of Health Sciences, University of Manchester, Manchester, UK., O'Gorman K; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia., McGorry PD; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia., Wood SJ; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.; Institute for Mental Health, University of Birmingham, Birmingham, UK., Berger GE; Orygen, Melbourne, Victoria, Australia.; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.

Publikováno v: Early intervention in psychiatry [Early Interv Psychiatry] 2024 Oct; Vol. 18 (10), pp. 859-868. Date of Electronic Publication: 2024 Apr 10.

A selective review of inhibitors of protein kinase C gamma: a neuroplasticity-related common pathway for psychiatric illness.

Autor: Grados, Marco, Salehi, Mona, Lotfi, Aida, Dua, Sagar, Xie, Isabella

Publikováno v: Frontiers in Drug Delivery; 9/27/2024, p1-18, 18p

The Effects of Serotonin~3 Receptor Blockade on the Psychobiological Response to Intravenous Clomipramine in Healthy Human Subjects

Autor: Leatherman, M. E., Bebchuk, J. M., Ekstrom, R. D., Heine, A. D., Carson, S. W., Golden, R. N.

Publikováno v: Biological Psychiatry; 1999, Vol. 45 Issue: 2 p238-240, 3p

ECT and mental retardation.

Autor: Bebchuk, J M, Barnhill, J, Dawkins, K

Publikováno v: American Journal of Psychiatry; Sep96, Vol. 153 Issue 9, p1231-1231, 1p

Staged Treatment in Early Psychosis: A sequential multiple assignment randomised trial of interventions for ultra high risk of psychosis patients.

Autor: Nelson, Barnaby^1,2 Barnaby.nelson@orygen.org.au, Amminger, G. Paul^1,2, Yuen, Hok Pan^1,2, Wallis, Nicky^1,2, J. Kerr, Melissa^1,2, Dixon, Lisa³, Carter, Cameron⁴, Loewy, Rachel⁵, Niendam, Tara A.⁴, Shumway, Martha⁵, Morris, Sarah⁶, Blasioli, Julie^1,2, Mcgorry, Patrick D.^1,2

Publikováno v: Early Intervention in Psychiatry. Jun2018, Vol. 12 Issue 3, p292-306. 15p. 1 Diagram, 3 Charts.